Use of Generic DMTs in Clinical Practice in RRMS
May 31st 2023Ahmed Zayed Obeidat MD, PhD; Ravi Dukkipati, MD; and Gabriel Pardo, MD, FAAN, comment on the use of generic DMTs in the treatment of RRMS, highlighting efficacy and safety data as well as level of equivalence to brand name treatments.
Strategies for Managing Changes in Cognitive Function in Multiple Sclerosis: Meghan Beier, PhD, MA
May 30th 2023In recognition of World MS Day, the health and rehabilitation psychologist at the Rowan Center for Behavioral Medicine discussed types of interventions for managing cognitive changes in patients with multiple sclerosis. [WATCH TIME: 5 minutes]
Educating the Public on the Common Risk Factors for Stroke Awareness: Brandon Giglio, MD
May 25th 2023The director of vascular neurology at NYU Langone Hospital in Brooklyn discussed the high prevalence of common risk factors for stroke, emphasizing the importance of early detection and management for prevention. [WATCH TIME: 4 minutes]
Balancing COVID-19 Infection Risk and Disease Control in Pediatric Onset MS: Teri Schreiner, MD
May 25th 2023The associate professor at the University of Colorado highlighted the limitations of standard care visits in collecting crucial data from pediatric multiple sclerosis centers. [WATCH TIME: 3 minutes]
Taking a Symptom-Based Approach to Parkinson Disease Psychosis: Aaron Ritter, MD
May 23rd 2023The director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute discussed the future of treating Parkinson disease psychosis, and potential ways to lower risk of poor long-term outcomes. [WATCH TIME: 3 minutes]
Pridopidine’s Impact on ALS, Assessing Results From HEALEY ALS Platform Trial: Melanie Leitner, PhD
May 23rd 2023The consultant and founder of Accelerating NeuroVentures talked about the pridopidine arm from the HEALEY ALS Platform trial, which showed significant benefits in speech measures. [WATCH TIME: 5 minutes]
Expanding Diversity in Neurology, Inclusive Communication and Accessibility: Diana M. Cejas, MD, MPH
May 19th 2023The assistant professor of neurology at the University of North Carolina at Chapel Hill discussed the importance of recognizing disability as part of diversity in neurology, emphasizing the need for inclusive communication and accessibility for disabled patients. [WATCH TIME: 10 minutes]
The Classification, Management, and Future Directions of Neonatal Seizures: Elissa Yozawitz, MD
May 19th 2023The associate professor of neurology at Albert Einstein College of Medicine talked about a review on neonatal seizures recently published in the New England Journal of Medicine. [WATCH TIME: 5 minutes]
Potential for Preventing NMOSD, Improving Access to Panel Testing: Sean Pittock, MD
May 18th 2023The director of the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology provided commentary on the possibility of preventing NMOSD, and the need to improve access to approved therapies and AQP4 testing. [WATCH TIME: 3 minutes]
Use of Neurofilament Light Chain (NfL) as a Biomarker in Multiple Sclerosis (MS)
May 18th 2023Bruce Hughes, MD, provides an overview of the use of neurofilament light chain (NfL) as a biomarker in multiple sclerosis (MS), highlighting the accuracy and reliability of plasma/serum NfL (pNfL) and cerebrospinal fluid (CSF) NfL measurements.